(+886) 2-2655-7790・(+886) 2-2655-8633 ext.3121

(+886) 2-2655-7730

Rm. ER12A, 17F.-1, No. 3, Park St., Nangang Dist., Taipei City 115, Taiwan (R.O.C.)​

選單

New Drug

GM-XANTHO

INDICATION
Atopic Dermatitis
MECHANISM
  • Anti-inflammatory
  • Decrease the expression of Th2 cytokines IL-10, IL-4, IgE and restore Th1/Th2 balance by suppressing the overexpression of  keratinocytes
STATUS
  • Phase II
ADVANTAGES
  • Botanical new drugs have high barriers to entry, and raw materials are difficult to obtain.
  • The effect is as good as steroids but not recur in AD
  • Safety and long-term use
MARKET

The Global Data estimates that in 2027, the sales were total $18.3B for atopic dermatitis worldwide.

  • The allergic reaction is a series of allergic and inflammatory reactions initiated by over-expression of the Th2 pathway in the body.
    GM-XANTHO is a botanical new drug for the treatment of Atopic Dermatitis. It can decrease the expression of Th2 cytokines IL-10, IL-4, IgE and restore Th1/Th2 balance by suppressing the overexpression of Cytokines of keratinocyte cells. GM-XANTHO potentially has both therapeutic and preventive effects in allergic disease.
  • GM-XANTHO has completed CMC, which has manufactured in accordance with GMP/PIS specifications. GM-XANTHO has completed pre-clinical pharmacology, pharmacokinetics and toxicity tests to confirm the efficacy of GM-XANTHO in the treatment of atopic dermatitis and has low side effects.